SCHEMBL20725836

SCHEMBL20725836

CCOC(=O)C(F)(F)C(O)CNC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 2/20 0.37
PKM P14618 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 2/20 0.36
RECQL P46063 1/20 0.36
THRB P10828 2/20 0.35
TAAR1 Q96RJ0 2/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAPT P10636 3/20 0.35
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 2/20 0.34
HIF1A Q16665 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL441786 0.81 ALDH1A1 (0.37) MMP8PKMKDM4EALDH1A1THRB
SCHEMBL12482713 0.78 MMP8 (0.35) MMP8PKMKDM4EALDH1A1THRB
SCHEMBL17801525 0.78 SYK (0.41) MMP8PKMKDM4EALDH1A1THRB
SCHEMBL892045 0.76 MMP8 (0.41) MMP8PKMKDM4EALDH1A1THRB
SCHEMBL7427206 0.75 SYK (0.50) MMP8ALDH1A1RECQLLMNAMAPT
SCHEMBL16492775 0.73 MMP8 (0.41) MMP8PKMKDM4EALDH1A1RECQL
SCHEMBL14504422 0.72 MMP8 (0.43) MMP8PKMKDM4EALDH1A1THRB
SCHEMBL954289 0.72 MMP8 (0.43) MMP8PKMKDM4EALDH1A1THRB
SCHEMBL1682735 0.72 CYP4F2 (0.41) MMP8PKMKDM4EALDH1A1RECQL
SCHEMBL8863698 0.72 MAPT (0.43) LMNAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227279-B1 1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS LILLY CO ELI (US) 2019-02-13 EP disclosed